Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist
- PMID: 35317885
- PMCID: PMC8984762
- DOI: 10.2500/aap.2022.43.220008
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist
Comment on
-
Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema.Allergy Asthma Proc. 2022 Mar 1;43(2):155-162. doi: 10.2500/aap.2022.43.220005. Allergy Asthma Proc. 2022. PMID: 35317893
Similar articles
-
The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.J Allergy Clin Immunol Pract. 2021 Jan;9(1):7-12. doi: 10.1016/j.jaip.2020.10.036. Epub 2020 Oct 28. J Allergy Clin Immunol Pract. 2021. PMID: 33130145 Free PMC article. Review.
-
Parosmia after COVID-19: olfactory training, neuroinflammation and distortions of smell.Eur Rev Med Pharmacol Sci. 2022 Jan;26(1):1-3. doi: 10.26355/eurrev_202201_27739. Eur Rev Med Pharmacol Sci. 2022. PMID: 35049034 No abstract available.
-
Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.Clin Exp Pharmacol Physiol. 2022 Apr;49(4):462-473. doi: 10.1111/1440-1681.13626. Epub 2022 Feb 10. Clin Exp Pharmacol Physiol. 2022. PMID: 35090056 Review.
-
Implementing a COVID-19 specialist smell clinic: experience at the Wrightington, Wigan and Leigh Teaching Hospitals (WWL), NHS Foundation Trust, United Kingdom.Med J Malaysia. 2021 Aug;76(Suppl 4):9-13. Med J Malaysia. 2021. PMID: 34558550
-
Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction.JAMA Netw Open. 2022 Sep 1;5(9):e2230637. doi: 10.1001/jamanetworkopen.2022.30637. JAMA Netw Open. 2022. PMID: 36074464 Free PMC article.
Cited by
-
Eosinophilic esophagitis: from discovery to effective treatment.Allergy Asthma Proc. 2022 May 1;43(3):175-177. doi: 10.2500/aap.2022.43.220025. Allergy Asthma Proc. 2022. PMID: 35524360 Free PMC article. No abstract available.
-
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.Allergy Asthma Proc. 2022 Nov 1;43(6):471-473. doi: 10.2500/aap.2022.43.220081. Allergy Asthma Proc. 2022. PMID: 36335419 Free PMC article. No abstract available.
-
From Acute Phase to Long COVID: A Cross-Sectional Study of the Epidemiological Profile and Clinical Evaluation of SARS-CoV-2 Infection in Employees at a Pediatric Hospital.J Clin Med. 2023 Jun 27;12(13):4325. doi: 10.3390/jcm12134325. J Clin Med. 2023. PMID: 37445359 Free PMC article.
-
Asthma biomarkers and COVID-19 continue to dominate current medical issues.Allergy Asthma Proc. 2022 Sep 1;43(5):363-367. doi: 10.2500/aap.2022.43.220062. Allergy Asthma Proc. 2022. PMID: 36065102 Free PMC article. No abstract available.
References
-
- Phillips S, Williams MA. Confronting our next national health disaster - long-haul COVID. N Engl J Med. 2021; 385:577–579. - PubMed
-
- Ramirez RM, V RL, Andrews CP. Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber. Allergy Asthma Proc. 2022; 43:116–123. - PubMed
-
- Wu G, Hu H, Zhang T, et al. . Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000 kU/L). Allergy Asthma Proc. 2022; 43:124–132. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical